Being Open About Mental Health Care During Cancer Treatment

Video

To combat the stigma around mental health care for patients with lung cancer, survivor Nancy Cohen shares her own treatment story and why she feels it's important to include mental health care during cancer treatment.

Patients go through many emotions after receiving a cancer diagnosis, especially those with lung cancer who face stigma associated with the disease, such as smoking led to their diagnosis. Stigmas like this can cause mental health distress for which patients may not seek support, according to Nancy Cohen, a lung cancer survivor turned patient advocate, who uses her voice to help others with the disease.

Cohen recently served as the keynote speaker during the CURE® Patient-Focused Sessions at the New York Lung Cancers Symposium® on Nov. 9 addressing a crowd of more than 80 patients with lung cancer. She shared her story to highlight that there is more to the treatment journey than just taking medication and going for routine visits. In an interview with CURE®, her address focused on how mental health care is just as important and shouldn’t be overlooked.

Transcription:

The other thing that is important is managing the mental health aspect of it. I started working with a therapist who specializes in oncology patients. And, I think, we can talk about the stigma of lung cancer and the stigma of mental health and sort of making sure that neither of those is present because I think, you know, going through this is hard enough. And, going through it with a mental health professional is so important.

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE